• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form F-6 POS filed by LAIX Inc.

    3/4/22 6:14:40 AM ET
    $LAIX
    Service to the Health Industry
    Miscellaneous
    Get the next $LAIX alert in real time by email
    F-6 POS 1 f-6_pos.htm F-6 REGISTRATION STATEMENT
    As filed with the Securities and Exchange Commission on March 4, 2022
     Registration No. 333-227351


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C.  20549
    _______________________________
    POST-EFFECTIVE AMENDMENT NO. 1 TO
    FORM F-6
    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FOR
    DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS
    ___________
    LAIX Inc.
    (Exact name of issuer of deposited securities as specified in its charter)
    ___________
    Not Applicable
    (Translation of issuer’s name into English)
    ___________
    Cayman Islands
    (Jurisdiction of incorporation or organization of issuer)
    ____________________________
    Deutsche Bank Trust Company Americas
    (Exact name of depositary as specified in its charter)
    1 Columbus Circle
    New York, New York 10019
    +1 (212) 250-9100
    (Address, including zip code, and telephone number, including area code, of depositary’s principal executive offices)
    ___________
    Puglisi & Associates
    850 Library Avenue, Suite 204
    Newark, Delaware 19711
    +1 302-738-6680
    (Address, including zip code, and telephone number, including area code, of agent for service)
    _________________________
    Copies to:
    Z. Julie Gao, Esq.
    Skadden, Arps, Slate, Meagher & Flom LLP
    c/o 42/F, Edinburgh Tower, The Landmark
    15 Queen’s Road Central
    Hong Kong
    +852 3740-4700
    Haiping Li, Esq.
    Skadden, Arps, Slate, Meagher & Flom LLP
    JingAn Kerry Centre, Tower II, 46/F
    1539 Nanjing West Road
    Shanghai, People’s Republic of China
    +86 21-61938200
    Melissa Butler, Esq.
    White & Case LLP
    5 Old Broad Street
    London EC2N 1DW
    United Kingdom
    +(44) 20 7532-1502
    _________________________________
    It is proposed that this filing become effective under Rule 466:
    ☒ immediately upon filing.
    ☐ on (Date) at (Time).
    If a separate registration statement has been filed to register the deposited shares, check the following box :  ☒
    _________________________________
    CALCULATION OF REGISTRATION FEE
    Title of each class
    of Securities to be registered
    Amount to be registered
    Proposed
    maximum aggregate price per unit (1)
    Proposed
    maximum aggregate offering price (2)
    Amount of registration fee(3)
    American Depositary Shares, each representing fourteen Class A ordinary shares of LAIX Inc.
    N/A
    N/A
    N/A
    N/A


    1
    For the purpose of this table only the term "unit" is defined as one American Depositary Share.
    2
    Estimated solely for the purpose of calculating the registration fee.  Pursuant to Rule 457(k), such estimate is computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of American Depositary Shares.
    3
    Previously paid.
       
    This registration statement may be executed in any number of counterparts, each of which shall be deemed an original, and all of such counterparts together shall constitute one and the same instrument.

    EXPLANATORY NOTE
    This Post-Effective Amendment No. 1 to the Registration Statement on Form F-6 (Registration No. 333-227351) is being filed solely to (i) effect a ratio change for each American Depositary Share so that the new ratio shall be one (1) American Depositary Share to fourteen (14) Class A ordinary shares of LAIX Inc. and (ii) make corresponding changes reflecting the ratio change to the previously filed Deposit Agreement.
    PART I


    INFORMATION REQUIRED IN PROSPECTUS
    The prospectus consists of the proposed form of American Depositary Receipt (“Receipt”) included as Exhibits A and B to the form of Amendment No. 1 to the Deposit Agreement filed as Exhibit (a)(ii) to this Post-Effective Amendment to the Registration Statement on Form F-6 (File No. 333-227351) previously filed by the Registrant, which is incorporated herein by reference.
    Item 1.
    DESCRIPTION OF SECURITIES TO BE REGISTERED

    Required Information
     
    Location in Form of Receipt Filed Herewith as Prospectus
             
    1.
    Name of depositary and address of its principal executive office
     
    Face of Receipt – introductory paragraph
             
    2.
    Title of Receipts and identity of deposited securities
     
    Face of Receipt – top center
             
    Terms of Deposit:
       
             
     
    (i)
    The amount of deposited securities represented by one American Depositary Share (“ADS”)
     
    Face of Receipt – upper right corner
             
     
    (ii)
    The procedure for voting the deposited securities
     
    Reverse of Receipt – Articles 14 and 15
             
     
    (iii)
    The procedure for collecting and distributing dividends
     
    Reverse of Receipt – Articles 13 and 14
             
     
    (iv)
    The procedures for transmitting notices, reports and proxy soliciting material
     
    Face of Receipt – Article 12;
    Reverse of Receipt – Articles 14 and 15
             
     
    (v)
    The sale or exercise of rights
     
    Reverse of Receipt – Articles 13 and 14
             
     
    (vi)
    The deposit or sale of securities resulting from dividends, splits or plans of reorganization
     
    Face of Receipt – Articles 3, 6 and 9;
    Reverse of Receipt – Articles 13 and 16
             
     
    (vii)
    Amendment, extension or termination of the deposit arrangements
     
    Reverse of Receipt – Articles 20 and 21 (no provision for extension)
             
     
    (viii)
    The rights of holders of Receipts to inspect the books of the depositary and the list of holders of Receipts
     
    Face of Receipt – Article 12
             
     
    (ix)
    Restrictions upon the right to transfer or withdraw the underlying securities
     
    Face of Receipt – Articles 2, 3, 4, 6, 8, 9 and 10;
    Reverse of Receipt – Article 22
             
     
    (x)
    Limitation on the depositary’s liability
     
    Face of Receipt – Articles 6 and 10;
    Reverse of Receipt – Articles 15, 16, 17 and 18
             
    3.
    Fees and charges that a holder of Receipts may have to pay, either directly or indirectly
     
    Face of Receipt – Article 9
           


    Item 2.
    AVAILABLE INFORMATION
    LAIX Inc. (the “Company”) is subject to the periodic reporting requirements of the United States Securities Exchange Act of 1934, as amended, and, accordingly, files certain reports with, and furnishes certain reports to, the U.S. Securities and Exchange Commission (the “Commission”).  These reports can be retrieved from the Commission’s website (www.sec.gov) and can be inspected and copied at the public reference facilities maintained by the Commission at 100 F Street, N.E., Washington D.C. 20549.
    PART II


    INFORMATION NOT REQUIRED IN PROSPECTUS
    Item 3.
    EXHIBITS

     
    (a)(i)
    Form of Deposit Agreement, by and among the Company, Deutsche Bank Trust Company Americas, as depositary (the “Depositary”), and all holders and beneficial owners from time to time of ADSs issued thereunder (“Deposit Agreement”).  — Previously filed as Exhibit (a) to Form F-6 (File No. 333-227351) and incorporated herein by reference.
         
     
    (a)(ii)
    Form of Amendment No. 1 to the Deposit Agreement— Filed herewith as Exhibit (a)(ii).
         
     
    (b)
    Any other agreement to which the Depositary is a party relating to the issuance of the ADSs registered hereunder or the custody of the deposited securities represented thereby. — Not applicable.
         
     
    (c)
    Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years. — Not applicable.
         
     
    (d)
    Opinion of White & Case LLP, counsel to the Depositary, as to the legality of the securities to be registered. — Previously filed as Exhibit (d) to Form F-6 (File No. 333-227351).
         
     
    (e)
    Certification under Rule 466. — Filed herewith as Exhibit (e).
         
     
    (f)
    Powers of attorney for certain officers and directors of the Company. — Set forth on the signature pages hereto.

    Item 4.
    UNDERTAKINGS

       (a)
    The Depositary hereby undertakes to make available at the principal office of the Depositary in theUnited States, for inspection by holders of the ADRs, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities; and (2) made generally available to the holders of the underlying securities by the issuer.
         
     
    (b)
    If the amount of fees charged is not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request.  The Depositary undertakes to notify each registered holder of an ADR thirty (30) days before any change in the fee schedule.


    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Post- Effective Amendment No. 1 to the Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on March 4, 2022.
     
    Legal entity created by the form of Deposit Agreement for the issuance of American Depositary Receipts for Class A ordinary shares, par value US$0.001 per share of LAIX Inc.
    Deutsche Bank Trust Company Americas, as Depositary
       
       
     
    By:
    /s/ Michael Fitzpatrick
     
       
    Name:
     Michael Fitzpatrick
     
       
    Title:
     Vice President
     
       
       
     
    By:
    /s/ Michael Curran
     
       
    Name:
     Michael Curran
     
       
    Title:
     Vice President
     


    Pursuant to the requirements of the Securities Act of 1933, as amended, LAIX Inc. certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Post-Effective Amendment No. 1 to Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in Shanghai, the People's Republic of China, on March 4, 2022.
     
    LAIX Inc.
       
       
     
    By:
    /s/ Yi Wang
     
       
    Name:
    Yi Wang
     
       
    Title:
    Chairman of the Board of Directors and Chief Executive Officer
     
       
       


    POWER OF ATTORNEY
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Yi Wang and Bing Sun, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective amendments) to this registration statement and any and all related registration statements pursuant to Rule 462(b) of the Securities Act and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
    Under the requirements of the Securities Act, this Post-Effective Amendment No.1 to the Registration Statement on Form F-6 has been signed by the following persons on March 4, 2022, in the capacities indicated.
    Signature
     
    Title
         
    /s/ Yi Wang
     
    Chairman of the Board of Directors
    and Chief Executive Officer
    (principal executive officer)
    Name:
    Yi Wang
       
         
    /s/ Zheren Hu
     
    Director
    Name:
    Zheren Hu
       
         
    /s/ Hui Lin
     
    Director
    Name:
    Hui Lin
       
         
    /s/ Li-Lan Cheng
     
    Director
    Name:
    Li-Lan Cheng
       
         
    /s/ Tiak Koon Loh
     
    Director
    Name:
    Tiak Koon Loh
       
         
    /s/ Min (Jenny) Zhang
     
    Director
    Name:
    Min (Jenny) Zhang
       
         
    /s/ Bing Sun
     
    Chief Financial Officer
    (principal financial and accounting officer)
    Name:
    Bing Sun
       
         


    SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES
    Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of LAIX Inc., has signed this Post-Effective Amendment No. 1 to the Registration Statement on Form F-6 in Newark, Delaware, United States of America on March 4, 2022.
     
    Puglisi & Associates
       
       
     
    By:
    /s/ Donald J. Puglisi
     
       
    Name:
    Donald J. Puglisi
     
       
    Title:
    Managing Director
     
       
       


    Index to Exhibits
    Exhibit
    Document
    (a)(ii)
    Form of Amendment No. 1 to the Deposit Agreement
    (e)
    Rule 466 Certification

    Get the next $LAIX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LAIX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LAIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Zhihu Inc. Announces Change of Independent Director

      BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui Sam Sun has resigned as an independent director of the Company, due to other professional endeavors. These changes are effective on May 27, 2025. For the committees under the board of directors, Dr. Li-Lan will serve as the chairman of the audit committee as well as a member of the compensation committee, nomination committee, and corporate governance committee. Dr. Li-Lan Cheng is currently an executive director and chief financial offic

      5/27/25 4:50:22 AM ET
      $YJ
      $ZH
      $JOBS
      $LAIX
      Other Specialty Stores
      Consumer Discretionary
      Business Services
      Diversified Commercial Services
    • LAIX Inc. Announces Plan to Implement ADS Ratio Change

      SHANGHAI, Feb. 21, 2022 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE:LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to its Class A ordinary shares (the "ADS Ratio"), par value US$0.001 per share, from the current ADS Ratio of one (1) ADS to one (1) Class A ordinary share to a new ADS Ratio of one (1) ADS to fourteen (14) Class A ordinary shares. A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed with the SEC to reflect the change in the ADS Ratio. The Company antic

      2/21/22 7:00:00 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • LAIX Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

      SHANGHAI, Sept. 28, 2021 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE:LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated September 17, 2021 and further e-mail communication on the same date, notifying the Company that (i) it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs"), and (ii) the applicable cure period for the Company to regain compliance expires on March 17, 2022. Pursuant to applicable NYSE continued listing stan

      9/28/21 7:00:00 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous

    $LAIX
    SEC Filings

    See more
    • SEC Form SC 13E3 filed by LAIX Inc.

      SC 13E3 - LAIX Inc. (0001742056) (Subject)

      7/11/22 8:52:23 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form 6-K filed by LAIX Inc.

      6-K - LAIX Inc. (0001742056) (Filer)

      6/27/22 4:02:01 PM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form 6-K filed by LAIX Inc.

      6-K - LAIX Inc. (0001742056) (Filer)

      6/17/22 9:10:37 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous

    $LAIX
    Leadership Updates

    Live Leadership Updates

    See more

    $LAIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Zhihu Inc. Announces Change of Independent Director

      BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui Sam Sun has resigned as an independent director of the Company, due to other professional endeavors. These changes are effective on May 27, 2025. For the committees under the board of directors, Dr. Li-Lan will serve as the chairman of the audit committee as well as a member of the compensation committee, nomination committee, and corporate governance committee. Dr. Li-Lan Cheng is currently an executive director and chief financial offic

      5/27/25 4:50:22 AM ET
      $YJ
      $ZH
      $JOBS
      $LAIX
      Other Specialty Stores
      Consumer Discretionary
      Business Services
      Diversified Commercial Services
    • SEC Form SC 13D/A filed by LAIX Inc. (Amendment)

      SC 13D/A - LAIX Inc. (0001742056) (Subject)

      7/8/22 1:51:02 PM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13D filed by LAIX Inc.

      SC 13D - LAIX Inc. (0001742056) (Subject)

      6/23/22 6:03:17 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13D/A filed by LAIX Inc. (Amendment)

      SC 13D/A - LAIX Inc. (0001742056) (Subject)

      6/21/22 6:17:08 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous